Erin Gainer-Grigaliūnė

Erin Gainer-Grigaliūnė is a global leader and strategist in women’s health pharmaceuticals, having served as CEO and then Chair of the Board of HRA Pharma, culminating in a trade sale in 2022. She is passionate about driving innovation to respond to unmet medical needs and is the author/inventor of dozens of peer-reviewed publications and patents. She currently advises life sciences companies and investors, serves as an independent director for public and private companies, and aims to accelerate innovation as a business angel and impact investor. Her interest in philanthropy started three decades ago with her time as a US Peace Corps volunteer and culminated in the creation of the ella fund, a gender-lens venture philanthropy fund devoted to backing innovation in education, health and entrepreneurship. 

A graduate from Rice University and John Hopkins School of Public Health, Erin has a PhD in epidemiology from Paris-Sud University and a Global Executive MBA from INSEAD (GEMBA ’08).